These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2212653)

  • 21. Effects of suramin-related and other clinically therapeutic polyanions on protein kinase C activity.
    Khaled Z; Rideout D; O'Driscoll KR; Petrylak D; Cacace A; Patel R; Chiang LC; Rotenberg S; Stein CA
    Clin Cancer Res; 1995 Jan; 1(1):113-22. PubMed ID: 9815893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A retroviral-derived peptide phosphorylates protein kinase D/protein kinase Cmu involving phospholipase C and protein kinase C.
    Luangwedchakarn V; Day NK; Hitchcock R; Brown PG; Lerner DL; Rucker RP; Cianciolo GJ; Good RA; Haraguchi S
    Peptides; 2003 May; 24(5):631-7. PubMed ID: 12895647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification, using synthetic peptides, of the minimum amino acid sequence from the retroviral transmembrane protein p15E required for inhibition of lymphoproliferation and its similarity to gp21 of human T-lymphotropic virus types I and II.
    Ruegg CL; Monell CR; Strand M
    J Virol; 1989 Aug; 63(8):3250-6. PubMed ID: 2746730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S100B(betabeta) inhibits the protein kinase C-dependent phosphorylation of a peptide derived from p53 in a Ca2+-dependent manner.
    Wilder PT; Rustandi RR; Drohat AC; Weber DJ
    Protein Sci; 1998 Mar; 7(3):794-8. PubMed ID: 9541413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-myristyl-Lys-Arg-Thr-Leu-Arg: a novel protein kinase C inhibitor.
    O'Brian CA; Ward NE; Liskamp RM; de Bont DB; van Boom JH
    Biochem Pharmacol; 1990 Jan; 39(1):49-57. PubMed ID: 2153382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel N-myristylated synthetic octapeptide inhibits protein kinase C activity and partially reverses murine fibrosarcoma cell resistance to adriamycin.
    O'Brian CA; Ward NE; Liskamp RM; de Bont DB; Earnest LE; van Boom JH; Fan D
    Invest New Drugs; 1991 May; 9(2):169-79. PubMed ID: 1874600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of protein kinase C inhibitory activity associated with a polypeptide isolated from a phage display system with homology to PCM-1, the pericentriolar material-1 protein.
    Chakravarthy B; Ménard M; Brown L; Atkinson T; Whitfield J
    Biochem Biophys Res Commun; 2012 Jul; 424(1):147-51. PubMed ID: 22732405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of protein kinase C by a synthetic peptide corresponding to cytoplasmic domain residues 828-848 of the human immunodeficiency virus type 1 envelope glycoprotein.
    Ward NE; Gravitt KR; O'Brian CA
    Cancer Lett; 1995 Jan; 88(1):37-40. PubMed ID: 7850771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of protein kinase C by N-myristoylated peptide substrate analogs.
    Ward NE; O'Brian CA
    Biochemistry; 1993 Nov; 32(44):11903-9. PubMed ID: 8218262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of interleukin-2 production by tumor cell products and by CKS-17, a synthetic retroviral envelope peptide.
    Nelson M; Nelson D
    Cancer Immunol Immunother; 1990; 30(6):331-41. PubMed ID: 2302724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resveratrol preferentially inhibits protein kinase C-catalyzed phosphorylation of a cofactor-independent, arginine-rich protein substrate by a novel mechanism.
    Stewart JR; Ward NE; Ioannides CG; O'Brian CA
    Biochemistry; 1999 Oct; 38(40):13244-51. PubMed ID: 10529197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pentacosapeptide (CKS-25) homologous to retroviral envelope proteins possesses a transforming growth factor-beta activity.
    Huang SS; Huang JS
    J Biol Chem; 1998 Feb; 273(9):4815-8. PubMed ID: 9478918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulation of the ATPase activity of rat brain protein kinase C by phospho acceptor substrates of the enzyme.
    O'Brian CA; Ward NE
    Biochemistry; 1991 Mar; 30(9):2549-54. PubMed ID: 1848101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins.
    Cianciolo GJ; Copeland TD; Oroszlan S; Snyderman R
    Science; 1985 Oct; 230(4724):453-5. PubMed ID: 2996136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of protein kinase C by defensins, antibiotic peptides from human neutrophils.
    Charp PA; Rice WG; Raynor RL; Reimund E; Kinkade JM; Ganz T; Selsted ME; Lehrer RI; Kuo JF
    Biochem Pharmacol; 1988 Mar; 37(5):951-6. PubMed ID: 3345204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Irreversible inactivation of protein kinase C by a peptide-substrate analog.
    Ward NE; Gravitt KR; O'Brian CA
    J Biol Chem; 1995 Apr; 270(14):8056-60. PubMed ID: 7713907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of the immunosuppressive activity of CKS-17, a synthetic retroviral envelope peptide, by muramyl dipeptide.
    Gauduin MC; Vogel FR; Simon JP; Audibert FA; Chedid LA
    Viral Immunol; 1993; 6(3):175-83. PubMed ID: 8292225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of CKS-17, a synthetic retroviral envelope peptide, on cell-mediated immunity in vivo: immunosuppression, immunogenicity, and relation to immunosuppressive tumor products.
    Nelson M; Nelson DS; Cianciolo GJ; Snyderman R
    Cancer Immunol Immunother; 1989; 30(2):113-8. PubMed ID: 2598177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of human interferon-gamma production by a 17 amino acid peptide homologous to the transmembrane envelope protein of retroviruses: evidence for a primary role played by monocytes.
    Haraguchi S; Liu WT; Cianciolo GJ; Good RA; Day NK
    Cell Immunol; 1992 May; 141(2):388-97. PubMed ID: 1576656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cobra venom cardiotoxin (cytotoxin) isoforms and neurotoxin: comparative potency of protein kinase C inhibition and cancer cell cytotoxicity and modes of enzyme inhibition.
    Chiou SH; Raynor RL; Zheng B; Chambers TC; Kuo JF
    Biochemistry; 1993 Mar; 32(8):2062-7. PubMed ID: 8448165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.